Kristine Cooper

1.0k total citations
29 papers, 740 citations indexed

About

Kristine Cooper is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Kristine Cooper has authored 29 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Kristine Cooper's work include Breast Cancer Treatment Studies (6 papers), Estrogen and related hormone effects (4 papers) and HER2/EGFR in Cancer Research (4 papers). Kristine Cooper is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Estrogen and related hormone effects (4 papers) and HER2/EGFR in Cancer Research (4 papers). Kristine Cooper collaborates with scholars based in United States, United Kingdom and Singapore. Kristine Cooper's co-authors include David J. Dabbs, Rohit Bhargava, Steffi Oesterreich, Nancy E. Davidson, Mamatha Chivukula, Jeremy M. G. Taylor, John T. Wei, László Pusztai, Beth Z. Clark and Uma Chandran and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Clinical Cancer Research.

In The Last Decade

Kristine Cooper

26 papers receiving 726 citations

Peers

Countries citing papers authored by Kristine Cooper

Since Specialization

Citations

This map shows the geographic impact of Kristine Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristine Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristine Cooper more than expected).

Fields of papers citing papers by Kristine Cooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristine Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristine Cooper. The network helps show where Kristine Cooper may publish in the future.

Co-authorship network of co-authors of Kristine Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Kristine Cooper. A scholar is included among the top collaborators of Kristine Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristine Cooper. Kristine Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic ancestry shapes dengue virus infection in human skin explants 2025 ·Proceedings of the National Academy of Sciences ·Priscila M. S. Castanha, (unknown), (unknown), (unknown), Kristine Cooper, (unknown), (unknown), Géza Erdös, (unknown), (unknown), J. Peter Rubin, Simon C. Watkins, Louis D. Falo, Ernesto T. A. Marques, Jeremy Martinson, Simon M. Barratt‐Boyes	1
2	TGFβ Inhibition during Radiotherapy Enhances Immune Cell Infiltration and Decreases Metastases in Ewing Sarcoma 2025 ·Cancer Research Communications ·(unknown), (unknown), (unknown), (unknown), Nathanael G. Bailey, (unknown), (unknown), (unknown), (unknown), Sheryl Kunning, Cynthia S. Hinck, Tullia C. Bruno, Adam C. Olson, Linda M. McAllister‐Lucas, Andrew P. Hinck, Kristine Cooper, Riyue Bao, Anthony R. Cillo, Kelly M. Bailey	0
3	De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression 2024 ·Cancer Research Communications ·(unknown), Raquel Buj, (unknown), Jiefei Wang, Aidan R. Cole, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Peter Sajjakulnukit, (unknown), Kristine Cooper, Nadine Hempel, Costas A. Lyssiotis, Uma Chandran, Nathaniel W. Snyder, Katherine M. Aird	4
4	614 T-regulatory cell depletion with E7777 combined with pembrolizumab in patients with recurrent solid tumors: phase I trial 2024 ·Regular and Young Investigator Award Abstracts ·Haider Mahdi, Kristine Cooper, (unknown), (unknown), (unknown), Sarah Taylor, Paniti Sukumvanich, Jamie Lesnock, Ronald J. Buckanovich, Lan Coffman, Robert P. Edwards, (unknown), M.M. Boisen, (unknown), Jessica Berger, Madeleine Courtney‐Brooks, (unknown), (unknown)	0
5	Evaluation of barriers to referral for cancer predisposition syndromes in pediatric oncology patients in the United States 2022 ·Journal of Genetic Counseling ·(unknown), Robin E. Grubs, E Kessler, Kristine Cooper, Kelly M. Bailey, (unknown)	6
6	The O-Ag Antibody Response to Francisella Is Distinct in Rodents and Higher Animals and Can Serve as a Correlate of Protection 2021 ·Pathogens ·(unknown), (unknown), Gabriela F. Giordano, Sudeep Kumar, (unknown), H. Carl Gelhaus, Eileen M. Barry, (unknown), Brian A. Hazlett, Kristine Cooper, Phillip R. Pittman, Douglas S. Reed, Karsten R. O. Hazlett	3
7	Performance of surgical site infection risk prediction models in colorectal surgery: external validity assessment from three European national surveillance networks 2019 ·Infection Control and Hospital Epidemiology ·Rebecca Grant, (unknown), Nicolas C. Buchs, Kristine Cooper, Marie‐Christine Eisenring, Theresa Lamagni, Frédéric Ris, (unknown), Nicolas Troillet, Stephan Harbarth, Mohamed Abbas	15
8	Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer 2016 ·Clinical Cancer Research ·Rekha Gyanchandani, Yan Lin, Hui‐Min Lin, Kristine Cooper, Daniel P. Normolle, Adam Brufsky, (unknown), (unknown), Steffi Oesterreich, Nancy E. Davidson, Rohit Bhargava, David J. Dabbs, Adrian V. Lee	53
9	Restraint and Social Isolation Stressors Differentially Regulate Adaptive Immunity and Tumor Angiogenesis in a Breast Cancer Mouse Model 2016 ·PubMed ·Raluca A. Budiu, Anda Vlad, (unknown), (unknown), Kristine Cooper, (unknown), Premal H. Thaker, Julie Urban, Paweł Kaliński, Adrian V. Lee, Esther Elishaev, Thomas P. Conrads, Melanie S. Flint	27
10	Dual HER2 Gene Protein Assay 2015 ·American Journal of Clinical Pathology ·Zaibo Li, David J. Dabbs, Kristine Cooper, Rohit Bhargava	11
11	Stress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damage 2015 ·British Journal of Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), Daniel Hochbaum, (unknown), Kristine Cooper, Steffi Oesterreich, Nancy E. Davidson, Carola A. Neumann, Melanie S. Flint	79
12	A Role for Histone H2B Variants in Endocrine-Resistant Breast Cancer 2015 ·Hormones and Cancer ·Shweta Nayak, (unknown), David N. Boone, Ryan J. Hartmaier, Jian Chen, Thushangi N. Pathiraja, Kristine Cooper, Jeffrey L. Fine, Joseph S. Sanfilippo, Nancy E. Davidson, Adrian V. Lee, David J. Dabbs, Steffi Oesterreich	32
13	Invasive Lobular Carcinoma Cell Lines Are Characterized by Unique Estrogen-Mediated Gene Expression Patterns and Altered Tamoxifen Response 2014 ·Cancer Research ·Matthew J. Sikora, Kristine Cooper, Amir Bahreini, Soumya Luthra, Guoying Wang, Uma Chandran, Nancy E. Davidson, David J. Dabbs, Alana L. Welm, Steffi Oesterreich	87
14	Bright-Field HER2 Dual In Situ Hybridization (DISH) Assay vs Fluorescence In Situ Hybridization (FISH) 2013 ·American Journal of Clinical Pathology ·(unknown), David J. Dabbs, Kristine Cooper, Rohit Bhargava	20
15	Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry 2013 ·Familial Cancer ·Meghan J. Walker, Lucia Mirea, Kristine Cooper, (unknown), Gord Glendon, Irene L. Andrulis, Julia A. Knight, Frances P. O’Malley, Anna M. Chiarelli	5
16	The Effect of 96-Hour Formalin Fixation on the Immunohistochemical Evaluation of Estrogen Receptor, Progesterone Receptor, and HER2 Expression in Invasive Breast Carcinoma 2012 ·American Journal of Clinical Pathology ·(unknown), David J. Dabbs, Kristine Cooper, Mamatha Chivukula, Kim McManus, Rohit Bhargava	19
17	Alcohol and Tobacco Lower the Age of Presentation in Sporadic Pancreatic Cancer in a Dose-Dependent Manner: A Multicenter Study 2012 ·The American Journal of Gastroenterology ·Michelle A. Anderson, (unknown), Kristine Cooper, Simon Sherman, (unknown), David C. Whitcomb, Henry T. Lynch, Paola Ghiorzo, Wendy S. Rubinstein, Kristen J. Vogel, Aaron R. Sasson, William E. Grizzle, (unknown), (unknown), Daniel P. Normolle, (unknown), (unknown), (unknown), Randall E. Brand	49
18	Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer 2011 ·Breast Cancer Research ·Rachel C. Jankowitz, Kristine Cooper, Mark G. Erlander, Xiaojun Ma, Nicole C. Kesty, Hongying Li, Mamatha Chivukula, Adam Brufsky	43
19	Racial disparities in resource utilization for cystectomy 2006 ·Urology ·David A. Taub, Brent K. Hollenbeck, Kristine Cooper, Rodney L. Dunn, David C. Miller, Jeremy M. G. Taylor, John T. Wei	40
20	Expression of tumour necrosis factor α and its receptors in carcinoma of the breast 1994 ·British Journal of Cancer ·László Pusztai, (unknown), Kristine Cooper, (unknown), (unknown), (unknown)	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact